- Trials with a EudraCT protocol (393)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (25)
393 result(s) found for: Hemodynamic.
Displaying page 1 of 20.
| EudraCT Number: 2020-005412-21 | Sponsor Protocol Number: DOBU-Whipple | Start Date*: 2021-04-06 |
| Sponsor Name:UZ Gent | ||
| Full Title: Effect of dobutamine on hepatic blood flow during goal-directed hemodynamic therapy. | ||
| Medical condition: Evaluating hepatic blood flow and caval & portal vein pressures during goal-directed hemodynamic therapy in patients undergoing pancreaticoduodenectomy. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-002834-36 | Sponsor Protocol Number: Retro-001 | Start Date*: 2012-09-13 |
| Sponsor Name:UMCG | ||
| Full Title: Evaluation of the effects of the addition of atropine during propofol/remifentanil induction of anesthesia on hemodynamics, microvascular blood flow and tissue oxygenenation in patients undergoing ... | ||
| Medical condition: ophthalmic surgery | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-003216-23 | Sponsor Protocol Number: UF8736 | Start Date*: Information not available in EudraCT |
| Sponsor Name:CHRU MONTPELLIER | ||
| Full Title: Intranasal Midazolam versus intranasal Ketamine to sedate newborns for intubation in delivery room | ||
| Medical condition: Maladie des membranes hyalines du nouveau-né (Code CIM : P22.OX-001) | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-000771-24 | Sponsor Protocol Number: CXL-1427-02 | Start Date*: 2014-12-22 | |||||||||||
| Sponsor Name:Cardioxyl Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Phase IIa Study of the Safety, Tolerability and Hemodynamic Effects of a Continuous 6-Hour Intravenous Infusion of CXL-1427 in Hospitalized Patients with Systolic Heart Failure | |||||||||||||
| Medical condition: Heart failure with reduced ejection fraction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-006135-12 | Sponsor Protocol Number: BalaCriCo | Start Date*: 2008-12-19 |
| Sponsor Name:Charité- University Medicine Berlin | ||
| Full Title: Balanced crystalloids versus balanced colloids within a goal-directed hemodynamic protocol in patients undergoing gynaecological tumor resection. Balancierte Kristalloide versus balancierte Kolloi... | ||
| Medical condition: The drugs Jonsteril and Volulyte6% will be investigated in female patients undergoing a tumor reduction operation. The study population will be female patients with metastatic ovarian carcinoma. Th... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-004473-14 | Sponsor Protocol Number: BAY 58-2667 / 11615 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Bayer HealthCare AG | ||
| Full Title: Proof of concept study to investigate the impact of BAY 58-2667 given intravenously in patients with acute decompensated chronic congestive heart failure | ||
| Medical condition: Critically ill patients, male and female, admitted to hospital with decompensated chronic congestive heart failure and clinical indication for parenteral pharmacotherapy with invasive hemodynamic m... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-004139-66 | Sponsor Protocol Number: AGO/2018/006 | Start Date*: 2019-04-11 |
| Sponsor Name:Ghent University Hospital | ||
| Full Title: Effect of norepinephrine infusion on hepatic blood flow during goal-directed hemodynamic therapy. | ||
| Medical condition: hepatic blood flow hepatic vascular pressures | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-002209-38 | Sponsor Protocol Number: 7418-503 | Start Date*: 2008-10-17 | |||||||||||
| Sponsor Name:NovaCardia, Inc. (A wholly owned subsidiary of Merck & Co., Inc.) | |||||||||||||
| Full Title: A multicenter, randomized, double-blind, placebo-controlled study of the hemodynamic effects of rolofylline injectable emulsion in the treatment of patients with heart failure | |||||||||||||
| Medical condition: Patients hospitalised with heart failure, volume overload and renal impairment, who require loop diuretic therapy and hemodynamic monitoring for clinical reasons | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Prematurely Ended) CZ (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-004328-39 | Sponsor Protocol Number: INFUTER | Start Date*: 2020-04-13 |
| Sponsor Name:Fundació Clínic per a la Recerca Biomèdica_FCRB | ||
| Full Title: Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension. A randomised, single blinded clinical trial. | ||
| Medical condition: The proposed study aims to investigate the hemodynamic effects of terlipressin and the time profile of these effects in patients with cirrhosis and portal hypertension when given as continuous infu... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-004319-29 | Sponsor Protocol Number: P170914J | Start Date*: 2021-10-04 | |||||||||||
| Sponsor Name:ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP) | |||||||||||||
| Full Title: " LEVOSIMENDAN to facilitate weaning from ECMO in severe cardiogenic shock patients | |||||||||||||
| Medical condition: Adult patients with acute cardiogenic shock refractory to conventional therapy placed on VA-ECMO support and for whom withdrawal from ECMO is possible. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-000748-24 | Sponsor Protocol Number: -- | Start Date*: 2018-08-09 |
| Sponsor Name:VUmc | ||
| Full Title: Partial neuromuscular blockade to facilitate lung and diaphragm protective mechanical ventilation in ICU patients. A randomized controlled pilot study. | ||
| Medical condition: Some patients develop high respiratory drive during partially supported mechanical ventilation which is associated with lung and diaphragm injury and worse clinical outcome | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000945-37 | Sponsor Protocol Number: PIRAD-001 | Start Date*: 2017-05-01 |
| Sponsor Name:UMCG | ||
| Full Title: Pharmacodynamic interactions between remifentanil and dexmedetomidine (PIRAD) | ||
| Medical condition: We will include 30 healthy volunteers (American Society of Anesthesiologists 1) stratified to age groups to different sequence of anesthesia regimen | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-004144-29 | Sponsor Protocol Number: lbnp_methoxy_fent_2019 | Start Date*: 2020-06-24 |
| Sponsor Name:Oslo University Hospital | ||
| Full Title: Methoxyflurane and fentanyl in hypovolemia induced by lower body negative pressure in healthy volunteers; A randomized, placebo-controlled crossover study | ||
| Medical condition: The study will investigate and compare the responses to experimental hypovolemia of methoxyflurane, fentanyl and placebo (NaCl) using the "lower body negative pressure" (LBNP)-model . | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NO (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-001479-22 | Sponsor Protocol Number: NCT03021525 | Start Date*: 2017-08-04 |
| Sponsor Name:University Medical Center Hamburg-Eppendorf, Germany | ||
| Full Title: Individualized perioperative hemodynamic goal-directed therapy in major abdominal surgery (iPEGASUS-trial) | ||
| Medical condition: - Hemodynamic Instability - Cardiac Output - High Peroperative Complication | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-002883-20 | Sponsor Protocol Number: WALIBI-001 | Start Date*: 2013-09-30 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Walking the Isobole of drug Interaction: Comparison of hemodynamic effects, cerebral and tissue oxygenation for 4 equipotent combinations of propofol and remifentanil | ||
| Medical condition: elective ophthalmic surgery under general anesthesia. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003182-34 | Sponsor Protocol Number: 2018-10 | Start Date*: 2018-10-18 |
| Sponsor Name:CHR d'ORLEANS | ||
| Full Title: Randomized, double-blind, controlled clinical trial for comparison of continuous phenylephrine versus norepinephrine infusion for maintenance of hemodynamic stability during cesarean section under... | ||
| Medical condition: hypotension during caesarean section under spinal anesthesia | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-002548-18 | Sponsor Protocol Number: Studie1hemodynami | Start Date*: 2016-10-04 |
| Sponsor Name:Karolinska Institutet Södersjukhuset | ||
| Full Title: Hemodynamic effects from administration of body temperature warmed versus room temperature fluid boluses in healthy volunteers | ||
| Medical condition: This trial will be a crossover study of healthy volunteers receiving a warm vs a cold fluid bolus to investigate the difference in hemodynamic response. While this will generate data for future stu... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-000071-18 | Sponsor Protocol Number: Teico HF | Start Date*: 2005-04-26 |
| Sponsor Name:Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine | ||
| Full Title: Pharmakokinetik von Teicoplanin bei kritisch Kranken während kontinuierlicher veno-venöser Hämofiltration und während Albumindialyse (Pharmacokinetics of teicoplanin in critically ill durining ven... | ||
| Medical condition: Plasma concentrations of teicoplanin will be measured in critically ill patients requirirng teicoplanin treatment for severe infection (proven or suspected infection with methicillin-resistant stap... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-006131-10 | Sponsor Protocol Number: APD418-201 | Start Date*: 2021-09-29 | |||||||||||
| Sponsor Name:Arena Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of APD418 in Subjects with Heart Failure wit... | |||||||||||||
| Medical condition: Treatment of acute heart failure with reduced ejection fraction (HFrEF) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2021-001954-76 | Sponsor Protocol Number: TV48531-CV-40190 | Start Date*: 2022-02-23 | |||||||||||
| Sponsor Name:Ratiopharm GmbH Teva EU Medical Affairs | |||||||||||||
| Full Title: A Randomized Open Label, Parallel Group Study to Evaluate the Hemodynamic Effects of Cafedrine/Theodrenaline vs Norepinephrine in the Treatment of Intraoperative Arterial Hypotension in Adults afte... | |||||||||||||
| Medical condition: The purpose of the study is to comparatively evaluate the hemodynamic effects of two treatments when intraoperative hypotension occurs. Patients who require advanced hemodynamic monitoring and dev... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
